Global Paclitaxel Drug-Eluting Balloon Market Growth 2026-2032
The global Paclitaxel Drug-Eluting Balloon market size is predicted to grow from US$ 1487 million in 2025 to US$ 3521 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
Paclitaxel drug-eluting balloons (often referred to as paclitaxel drug-coated balloons, DCBs) are endovascular angioplasty balloons coated with paclitaxel plus an excipient/carrier system engineered for rapid, localized drug transfer. During inflation, the device delivers mechanical lumen gain while depositing paclitaxel into the vessel wall to inhibit smooth-muscle cell proliferation and migration, thereby reducing restenosis and repeat interventions. The clinical and commercial proposition centers on ?leave nothing behind?: achieving durable antiproliferative effect without a permanent implant, which helps avoid the long-term burden of metallic scaffolds such as chronic inflammation, imaging artifacts, and constraints on future revascularization. Paclitaxel DEBs are particularly relevant in peripheral arterial disease (e.g., femoropopliteal lesions), dialysis access maintenance, and selected coronary scenarios including in-stent restenosis and small-vessel disease. Differentiation increasingly hinges on drug crystallinity, coating integrity, and transfer efficiency enabled by manufacturing know-how.In 2025, global Paclitaxel drug-eluting balloons production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Growth is shifting from ?device substitution? toward broader adoption of a standardized vascular-repair strategy. The regulatory and evidence boundary has become clearer: the U.S. FDA updated its communication noting that the totality of available data does not support an excess mortality risk for paclitaxel-coated devices used to treat PAD, enabling more actionable hospital governance and pathway deployment. In parallel, leading multinationals continue to highlight the momentum and acceptance of drug-coated balloon portfolios in annual reporting, underscoring rising strategic weight as peripheral intervention evolves ?from implants to repair.?
The main hurdle is no longer ?does it work,? but ?can it scale compliantly and sustainably.? Although paclitaxel safety concerns have substantially de-risked, long-term follow-up and real-world evidence will remain under scrutiny?making lifecycle risk management and manufacturing consistency non-negotiable. Meanwhile, procurement and cost-containment mechanisms intensify competition beyond performance into supply assurance and quality systems; in China, centralized procurement dynamics accelerate a more rules-based, scale-driven market phase, pushing manufacturers to harden cost efficiency, delivery reliability, and compliance capabilities.
Demand is moving toward ?adjunct devices + repeatable technique.? Clinicians increasingly integrate lesion preparation, optimized drug transfer, and long-term outcomes into a single procedural narrative, strengthening combination use of paclitaxel DEBs with atherectomy/plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). At the same time, high-recurrence, reintervention-sensitive settings (e.g., femoropopliteal disease and dialysis access) favor an implant-avoidance philosophy, broadening hospital-level adoption of the ?leave nothing behind? value proposition.
Upstream differentiation is ultimately a coupled ?materials + process chain? capability. Key inputs include balloon and catheter polymers (films, multi-durometer shafts, liners, and reinforcement braids/coils), paclitaxel API with crystallinity control, excipient/carrier systems and coating solvents, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Compared with standard PTA balloons, paclitaxel DEBs are far more sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and stability?requiring medical-grade traceability, rigorous change control, clean manufacturing, and deeper co-development/validation lock-in with upstream partners.
LP Information, Inc. (LPI) ' newest research report, the ?Paclitaxel Drug-Eluting Balloon Industry Forecast? looks at past sales and reviews total world Paclitaxel Drug-Eluting Balloon sales in 2025, providing a comprehensive analysis by region and market sector of projected Paclitaxel Drug-Eluting Balloon sales for 2026 through 2032. With Paclitaxel Drug-Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel Drug-Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel Drug-Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel Drug-Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Paclitaxel Drug-Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel Drug-Eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel Drug-Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Drug-Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Paclitaxel drug-eluting balloons (often referred to as paclitaxel drug-coated balloons, DCBs) are endovascular angioplasty balloons coated with paclitaxel plus an excipient/carrier system engineered for rapid, localized drug transfer. During inflation, the device delivers mechanical lumen gain while depositing paclitaxel into the vessel wall to inhibit smooth-muscle cell proliferation and migration, thereby reducing restenosis and repeat interventions. The clinical and commercial proposition centers on ?leave nothing behind?: achieving durable antiproliferative effect without a permanent implant, which helps avoid the long-term burden of metallic scaffolds such as chronic inflammation, imaging artifacts, and constraints on future revascularization. Paclitaxel DEBs are particularly relevant in peripheral arterial disease (e.g., femoropopliteal lesions), dialysis access maintenance, and selected coronary scenarios including in-stent restenosis and small-vessel disease. Differentiation increasingly hinges on drug crystallinity, coating integrity, and transfer efficiency enabled by manufacturing know-how.In 2025, global Paclitaxel drug-eluting balloons production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Growth is shifting from ?device substitution? toward broader adoption of a standardized vascular-repair strategy. The regulatory and evidence boundary has become clearer: the U.S. FDA updated its communication noting that the totality of available data does not support an excess mortality risk for paclitaxel-coated devices used to treat PAD, enabling more actionable hospital governance and pathway deployment. In parallel, leading multinationals continue to highlight the momentum and acceptance of drug-coated balloon portfolios in annual reporting, underscoring rising strategic weight as peripheral intervention evolves ?from implants to repair.?
The main hurdle is no longer ?does it work,? but ?can it scale compliantly and sustainably.? Although paclitaxel safety concerns have substantially de-risked, long-term follow-up and real-world evidence will remain under scrutiny?making lifecycle risk management and manufacturing consistency non-negotiable. Meanwhile, procurement and cost-containment mechanisms intensify competition beyond performance into supply assurance and quality systems; in China, centralized procurement dynamics accelerate a more rules-based, scale-driven market phase, pushing manufacturers to harden cost efficiency, delivery reliability, and compliance capabilities.
Demand is moving toward ?adjunct devices + repeatable technique.? Clinicians increasingly integrate lesion preparation, optimized drug transfer, and long-term outcomes into a single procedural narrative, strengthening combination use of paclitaxel DEBs with atherectomy/plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). At the same time, high-recurrence, reintervention-sensitive settings (e.g., femoropopliteal disease and dialysis access) favor an implant-avoidance philosophy, broadening hospital-level adoption of the ?leave nothing behind? value proposition.
Upstream differentiation is ultimately a coupled ?materials + process chain? capability. Key inputs include balloon and catheter polymers (films, multi-durometer shafts, liners, and reinforcement braids/coils), paclitaxel API with crystallinity control, excipient/carrier systems and coating solvents, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Compared with standard PTA balloons, paclitaxel DEBs are far more sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and stability?requiring medical-grade traceability, rigorous change control, clean manufacturing, and deeper co-development/validation lock-in with upstream partners.
LP Information, Inc. (LPI) ' newest research report, the ?Paclitaxel Drug-Eluting Balloon Industry Forecast? looks at past sales and reviews total world Paclitaxel Drug-Eluting Balloon sales in 2025, providing a comprehensive analysis by region and market sector of projected Paclitaxel Drug-Eluting Balloon sales for 2026 through 2032. With Paclitaxel Drug-Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel Drug-Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel Drug-Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel Drug-Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Paclitaxel Drug-Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel Drug-Eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel Drug-Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Drug-Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Peripheral DEB
- Coronary DEB
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Cardiac Catheterization Lab
- Hospital
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi Biotechnology
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
- Teleflex
- What is the 10-year outlook for the global Paclitaxel Drug-Eluting Balloon market?
- What factors are driving Paclitaxel Drug-Eluting Balloon market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doPaclitaxel Drug-Eluting Balloon market opportunities vary by end market size?
- How does Paclitaxel Drug-Eluting Balloon break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Country/Region, 2021, 2025 & 2032
2.2 Paclitaxel Drug-Eluting Balloon Segment by Type
2.2.1 Peripheral DEB
2.2.2 Coronary DEB
2.2.3 Paclitaxel Drug-Eluting Balloon Sales by Type
2.2.3.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
2.2.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2021-2026)
2.3 Paclitaxel Drug-Eluting Balloon Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Paclitaxel Drug-Eluting Balloon Sales by Use Scenario
2.3.4.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Use Scenario (2021-2026)
2.4 Paclitaxel Drug-Eluting Balloon Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Paclitaxel Drug-Eluting Balloon Sales by Balloon Platform Mechanics
2.4.4.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Paclitaxel Drug-Eluting Balloon Segment by Application
2.5.1 Cardiac Catheterization Lab
2.5.2 Hospital
2.5.3 Other
2.5.4 Paclitaxel Drug-Eluting Balloon Sales by Application
2.5.4.1 Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2021-2026)
2.5.4.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Paclitaxel Drug-Eluting Balloon Breakdown Data by Company
3.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Company (2021-2026)
3.1.2 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2021-2026)
3.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Company (2021-2026)
3.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2021-2026)
3.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2021-2026)
3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Company
3.4 Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Drug-Eluting Balloon Product Location Distribution
3.4.2 Players Paclitaxel Drug-Eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Geographic Region (2021-2026)
4.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Country/Region (2021-2026)
4.2.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Country/Region (2021-2026)
4.2.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Paclitaxel Drug-Eluting Balloon Sales Growth
4.4 APAC Paclitaxel Drug-Eluting Balloon Sales Growth
4.5 Europe Paclitaxel Drug-Eluting Balloon Sales Growth
4.6 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country
5.1.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026)
5.1.2 Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026)
5.2 Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
5.3 Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region
6.1.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2021-2026)
6.1.2 APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2021-2026)
6.2 APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
6.3 APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paclitaxel Drug-Eluting Balloon by Country
7.1.1 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026)
7.1.2 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026)
7.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
7.3 Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon by Country
8.1.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026)
8.1.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026)
8.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
8.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon
10.3 Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
10.4 Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel Drug-Eluting Balloon Distributors
11.3 Paclitaxel Drug-Eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Paclitaxel Drug-Eluting Balloon Market Size Forecast by Region
12.1.1 Global Paclitaxel Drug-Eluting Balloon Forecast by Region (2027-2032)
12.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Paclitaxel Drug-Eluting Balloon Forecast by Type (2027-2032)
12.7 Global Paclitaxel Drug-Eluting Balloon Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.1.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.2.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.3.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.4.3 BD Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.6.3 Acotec Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.7.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.8.3 Lepu Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.9.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.10.3 MicroPort Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.11.3 Teleflex Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Country/Region, 2021, 2025 & 2032
2.2 Paclitaxel Drug-Eluting Balloon Segment by Type
2.2.1 Peripheral DEB
2.2.2 Coronary DEB
2.2.3 Paclitaxel Drug-Eluting Balloon Sales by Type
2.2.3.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
2.2.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2021-2026)
2.3 Paclitaxel Drug-Eluting Balloon Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Paclitaxel Drug-Eluting Balloon Sales by Use Scenario
2.3.4.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Use Scenario (2021-2026)
2.4 Paclitaxel Drug-Eluting Balloon Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Paclitaxel Drug-Eluting Balloon Sales by Balloon Platform Mechanics
2.4.4.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Paclitaxel Drug-Eluting Balloon Segment by Application
2.5.1 Cardiac Catheterization Lab
2.5.2 Hospital
2.5.3 Other
2.5.4 Paclitaxel Drug-Eluting Balloon Sales by Application
2.5.4.1 Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2021-2026)
2.5.4.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Paclitaxel Drug-Eluting Balloon Breakdown Data by Company
3.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Company (2021-2026)
3.1.2 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2021-2026)
3.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Company (2021-2026)
3.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2021-2026)
3.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2021-2026)
3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Company
3.4 Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Drug-Eluting Balloon Product Location Distribution
3.4.2 Players Paclitaxel Drug-Eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Geographic Region (2021-2026)
4.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Country/Region (2021-2026)
4.2.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Country/Region (2021-2026)
4.2.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Country/Region (2021-2026)
4.3 Americas Paclitaxel Drug-Eluting Balloon Sales Growth
4.4 APAC Paclitaxel Drug-Eluting Balloon Sales Growth
4.5 Europe Paclitaxel Drug-Eluting Balloon Sales Growth
4.6 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country
5.1.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026)
5.1.2 Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026)
5.2 Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
5.3 Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region
6.1.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2021-2026)
6.1.2 APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2021-2026)
6.2 APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
6.3 APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paclitaxel Drug-Eluting Balloon by Country
7.1.1 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026)
7.1.2 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026)
7.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
7.3 Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon by Country
8.1.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026)
8.1.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026)
8.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026)
8.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon
10.3 Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
10.4 Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel Drug-Eluting Balloon Distributors
11.3 Paclitaxel Drug-Eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Paclitaxel Drug-Eluting Balloon Market Size Forecast by Region
12.1.1 Global Paclitaxel Drug-Eluting Balloon Forecast by Region (2027-2032)
12.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Paclitaxel Drug-Eluting Balloon Forecast by Type (2027-2032)
12.7 Global Paclitaxel Drug-Eluting Balloon Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.1.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.2.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.3.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.4.3 BD Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.6.3 Acotec Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.7.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.8.3 Lepu Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.9.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.10.3 MicroPort Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.11.3 Teleflex Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEB
Table 4. Major Players of Coronary DEB
Table 5. Global Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 6. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Table 7. Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2021-2026) & ($ million)
Table 8. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2021-2026)
Table 9. Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Paclitaxel Drug-Eluting Balloon Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Paclitaxel Drug-Eluting Balloon Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Paclitaxel Drug-Eluting Balloon Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Paclitaxel Drug-Eluting Balloon Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Paclitaxel Drug-Eluting Balloon Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Paclitaxel Drug-Eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Paclitaxel Drug-Eluting Balloon Sale by Application (2021-2026) & (K Units)
Table 27. Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2021-2026)
Table 28. Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2021-2026) & ($ million)
Table 29. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2021-2026)
Table 30. Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Paclitaxel Drug-Eluting Balloon Sales by Company (2021-2026) & (K Units)
Table 32. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2021-2026)
Table 33. Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2021-2026)
Table 35. Global Paclitaxel Drug-Eluting Balloon Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution and Sales Area
Table 37. Players Paclitaxel Drug-Eluting Balloon Products Offered
Table 38. Paclitaxel Drug-Eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Geographic Region (2021-2026)
Table 43. Global Paclitaxel Drug-Eluting Balloon Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Paclitaxel Drug-Eluting Balloon Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2021-2026)
Table 47. Global Paclitaxel Drug-Eluting Balloon Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 50. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021-2026)
Table 51. Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 53. Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 54. APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2021-2026) & (K Units)
Table 55. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2021-2026)
Table 56. APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 58. APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 59. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 60. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 62. Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Paclitaxel Drug-Eluting Balloon
Table 68. Key Market Challenges & Risks of Paclitaxel Drug-Eluting Balloon
Table 69. Key Industry Trends of Paclitaxel Drug-Eluting Balloon
Table 70. Paclitaxel Drug-Eluting Balloon Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Paclitaxel Drug-Eluting Balloon Distributors List
Table 73. Paclitaxel Drug-Eluting Balloon Customer List
Table 74. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. B. Braun Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 90. B. Braun Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Medtronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 94. Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 95. Medtronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Medtronic Main Business
Table 97. Medtronic Latest Developments
Table 98. Boston Scientific Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 99. Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 100. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boston Scientific Main Business
Table 102. Boston Scientific Latest Developments
Table 103. BD Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 105. BD Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BD Main Business
Table 107. BD Latest Developments
Table 108. Yinyi Biotechnology Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 109. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 110. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Yinyi Biotechnology Main Business
Table 112. Yinyi Biotechnology Latest Developments
Table 113. Acotec Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 114. Acotec Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 115. Acotec Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Acotec Main Business
Table 117. Acotec Latest Developments
Table 118. Philips Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 120. Philips Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Lepu Medical Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 124. Lepu Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 125. Lepu Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Lepu Medical Main Business
Table 127. Lepu Medical Latest Developments
Table 128. Eurocor Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 129. Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 130. Eurocor Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Eurocor Main Business
Table 132. Eurocor Latest Developments
Table 133. MicroPort Medical Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 134. MicroPort Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 135. MicroPort Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. MicroPort Medical Main Business
Table 137. MicroPort Medical Latest Developments
Table 138. Teleflex Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 139. Teleflex Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 140. Teleflex Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Teleflex Main Business
Table 142. Teleflex Latest Developments
Table 1. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peripheral DEB
Table 4. Major Players of Coronary DEB
Table 5. Global Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 6. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Table 7. Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2021-2026) & ($ million)
Table 8. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2021-2026)
Table 9. Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Paclitaxel Drug-Eluting Balloon Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Paclitaxel Drug-Eluting Balloon Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Paclitaxel Drug-Eluting Balloon Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Paclitaxel Drug-Eluting Balloon Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Paclitaxel Drug-Eluting Balloon Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Paclitaxel Drug-Eluting Balloon Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Paclitaxel Drug-Eluting Balloon Sale by Application (2021-2026) & (K Units)
Table 27. Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2021-2026)
Table 28. Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2021-2026) & ($ million)
Table 29. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2021-2026)
Table 30. Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Paclitaxel Drug-Eluting Balloon Sales by Company (2021-2026) & (K Units)
Table 32. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2021-2026)
Table 33. Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2021-2026)
Table 35. Global Paclitaxel Drug-Eluting Balloon Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution and Sales Area
Table 37. Players Paclitaxel Drug-Eluting Balloon Products Offered
Table 38. Paclitaxel Drug-Eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Geographic Region (2021-2026)
Table 43. Global Paclitaxel Drug-Eluting Balloon Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Paclitaxel Drug-Eluting Balloon Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2021-2026)
Table 47. Global Paclitaxel Drug-Eluting Balloon Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 50. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021-2026)
Table 51. Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 53. Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 54. APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2021-2026) & (K Units)
Table 55. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2021-2026)
Table 56. APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 58. APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 59. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 60. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 62. Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Paclitaxel Drug-Eluting Balloon
Table 68. Key Market Challenges & Risks of Paclitaxel Drug-Eluting Balloon
Table 69. Key Industry Trends of Paclitaxel Drug-Eluting Balloon
Table 70. Paclitaxel Drug-Eluting Balloon Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Paclitaxel Drug-Eluting Balloon Distributors List
Table 73. Paclitaxel Drug-Eluting Balloon Customer List
Table 74. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. B. Braun Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 90. B. Braun Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Medtronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 94. Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 95. Medtronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Medtronic Main Business
Table 97. Medtronic Latest Developments
Table 98. Boston Scientific Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 99. Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 100. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boston Scientific Main Business
Table 102. Boston Scientific Latest Developments
Table 103. BD Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 105. BD Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BD Main Business
Table 107. BD Latest Developments
Table 108. Yinyi Biotechnology Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 109. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 110. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Yinyi Biotechnology Main Business
Table 112. Yinyi Biotechnology Latest Developments
Table 113. Acotec Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 114. Acotec Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 115. Acotec Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Acotec Main Business
Table 117. Acotec Latest Developments
Table 118. Philips Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 120. Philips Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Lepu Medical Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 124. Lepu Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 125. Lepu Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Lepu Medical Main Business
Table 127. Lepu Medical Latest Developments
Table 128. Eurocor Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 129. Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 130. Eurocor Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Eurocor Main Business
Table 132. Eurocor Latest Developments
Table 133. MicroPort Medical Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 134. MicroPort Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 135. MicroPort Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. MicroPort Medical Main Business
Table 137. MicroPort Medical Latest Developments
Table 138. Teleflex Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 139. Teleflex Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 140. Teleflex Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Teleflex Main Business
Table 142. Teleflex Latest Developments
LIST OF FIGURES
Figure 1. Picture of Paclitaxel Drug-Eluting Balloon
Figure 2. Paclitaxel Drug-Eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Drug-Eluting Balloon Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Paclitaxel Drug-Eluting Balloon Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2025)
Figure 10. Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEB
Figure 12. Product Picture of Coronary DEB
Figure 13. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type in 2026
Figure 14. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Use Scenario in 2026
Figure 19. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Paclitaxel Drug-Eluting Balloon Consumed in Cardiac Catheterization Lab
Figure 26. Global Paclitaxel Drug-Eluting Balloon Market: Cardiac Catheterization Lab (2021-2026) & (K Units)
Figure 27. Paclitaxel Drug-Eluting Balloon Consumed in Hospital
Figure 28. Global Paclitaxel Drug-Eluting Balloon Market: Hospital (2021-2026) & (K Units)
Figure 29. Paclitaxel Drug-Eluting Balloon Consumed in Other
Figure 30. Global Paclitaxel Drug-Eluting Balloon Market: Other (2021-2026) & (K Units)
Figure 31. Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2025)
Figure 32. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application in 2026
Figure 33. Paclitaxel Drug-Eluting Balloon Sales by Company in 2026 (K Units)
Figure 34. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company in 2026
Figure 35. Paclitaxel Drug-Eluting Balloon Revenue by Company in 2026 ($ millions)
Figure 36. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company in 2026
Figure 37. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 40. Americas Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 41. APAC Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 42. APAC Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 43. Europe Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 44. Europe Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 47. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2026
Figure 48. Americas Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 49. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 50. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 51. United States Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region in 2026
Figure 56. APAC Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2021-2026)
Figure 57. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 58. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 59. China Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 63. India Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2026
Figure 67. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 68. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 69. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 70. Germany Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 71. France Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 78. Egypt Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon in 2026
Figure 84. Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
Figure 85. Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
Figure 86. Channels of Distribution
Figure 87. Global Paclitaxel Drug-Eluting Balloon Sales Market Forecast by Region (2027-2032)
Figure 88. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Paclitaxel Drug-Eluting Balloon
Figure 2. Paclitaxel Drug-Eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Drug-Eluting Balloon Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Paclitaxel Drug-Eluting Balloon Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2025)
Figure 10. Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Peripheral DEB
Figure 12. Product Picture of Coronary DEB
Figure 13. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type in 2026
Figure 14. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Use Scenario in 2026
Figure 19. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Paclitaxel Drug-Eluting Balloon Consumed in Cardiac Catheterization Lab
Figure 26. Global Paclitaxel Drug-Eluting Balloon Market: Cardiac Catheterization Lab (2021-2026) & (K Units)
Figure 27. Paclitaxel Drug-Eluting Balloon Consumed in Hospital
Figure 28. Global Paclitaxel Drug-Eluting Balloon Market: Hospital (2021-2026) & (K Units)
Figure 29. Paclitaxel Drug-Eluting Balloon Consumed in Other
Figure 30. Global Paclitaxel Drug-Eluting Balloon Market: Other (2021-2026) & (K Units)
Figure 31. Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2025)
Figure 32. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application in 2026
Figure 33. Paclitaxel Drug-Eluting Balloon Sales by Company in 2026 (K Units)
Figure 34. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company in 2026
Figure 35. Paclitaxel Drug-Eluting Balloon Revenue by Company in 2026 ($ millions)
Figure 36. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company in 2026
Figure 37. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 40. Americas Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 41. APAC Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 42. APAC Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 43. Europe Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 44. Europe Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue 2021-2026 ($ millions)
Figure 47. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2026
Figure 48. Americas Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 49. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 50. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 51. United States Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region in 2026
Figure 56. APAC Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2021-2026)
Figure 57. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 58. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 59. China Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 63. India Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2026
Figure 67. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2021-2026)
Figure 68. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 69. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 70. Germany Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 71. France Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2021-2026)
Figure 78. Egypt Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Paclitaxel Drug-Eluting Balloon Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon in 2026
Figure 84. Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
Figure 85. Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
Figure 86. Channels of Distribution
Figure 87. Global Paclitaxel Drug-Eluting Balloon Sales Market Forecast by Region (2027-2032)
Figure 88. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Application (2027-2032)
